Ads

 

Ads

 

Ads

 

Nasdaq Top Companies List by Market Cap as of January 2024

Nasdaq Top Companies List by Market Cap as of Jan-05-2024, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of Jan-05-2024.
Metatag Title
Nasdaq Largest and Top 1,000 Companies List in 2024
Metatag Abstract
Nasdaq Largest 1,000 Companies List by Market Cap in 2024, Nasdaq Top 1,000 Companies List by Market Cap in 2024.
  1. Himax Technologies

    World Rank (Jan-05-2024)
    8,346
    Market Cap (Jan-05-2024)
    1.050 Billion USD
    World Rank (Jul-30-2023)
    7,846
    Market Cap (Jul-30-2023)
    1.202 Billion USD
    World Rank (Dec-25-2022)
    7,612
    Market Cap (Dec-25-2022)
    1.178 Billion USD
    World Rank (Jan-07-2022)
    6,024
    Market Cap (Jan-07-2022)
    2.14 Billion USD
    Annual Revenue in USD
    1,547 Million USD
    Annual Net Income in USD
    436 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Himax Technologies is a fabless semiconductor solution company provider dedicated to display imaging processing technologies. The headquarters is in Taiwan.

  2. Nuveen Nasdaq 100 Dynamic Overwrite Fund

    World Rank (Jan-05-2024)
    8,131
    Market Cap (Jan-05-2024)
    1.095 Billion USD
    World Rank (Jul-30-2023)
    7,847
    Market Cap (Jul-30-2023)
    1.202 Billion USD
    World Rank (Dec-25-2022)
    8,574
    Market Cap (Dec-25-2022)
    0.962 Billion USD
    World Rank (Jan-07-2022)
    8,246
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    220 Million USD
    Annual Net Income in USD
    219 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. Sun Country Airlines Holdings Inc.

    World Rank (Jan-05-2024)
    9,854
    Market Cap (Jan-05-2024)
    0.788 Billion USD
    World Rank (Jul-30-2023)
    7,857
    Market Cap (Jul-30-2023)
    1.199 Billion USD
    World Rank (Dec-25-2022)
    8,743
    Market Cap (Dec-25-2022)
    0.928 Billion USD
    World Rank (Jan-07-2022)
    7,130
    Market Cap (Jan-07-2022)
    1.62 Billion USD
    Annual Revenue in USD
    894 Million USD
    Annual Operating Income in USD
    56 Million USD
    Annual Net Income in USD
    18 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Sun Country Airlines Holdings, Inc. is a passenger airlines company such as flight crews, across scheduled service, charter and cargo business lines with the objective of generating higher returns and margins and mitigating the seasonality of route network. The company annual revenue is 623 million USD and annual net income is 77 million USD for year ending Dec-2021. The headquarters is in USA.
  4. Arvinas

    World Rank (Jan-05-2024)
    5,263
    Market Cap (Jan-05-2024)
    2.279 Billion USD
    World Rank (Jul-30-2023)
    7,862
    Market Cap (Jul-30-2023)
    1.197 Billion USD
    World Rank (Dec-25-2022)
    5,940
    Market Cap (Dec-25-2022)
    1.741 Billion USD
    World Rank (Jan-07-2022)
    4,198
    Market Cap (Jan-07-2022)
    3.65 Billion USD
    Annual Revenue in USD
    131 Million USD
    Annual Operating Income in USD
    -263 Million USD
    Annual Net Income in USD
    -282 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Arvinas is a Clinical Stage Biopharmaceutical company. It is focused on developing new therapeutics for cancers and other difficult to treat diseases and on high value targets in cancer including the androgen and estrogen receptors associated with prostate and breast cancers, respectively. The headquarters is in USA.

  5. CymaBay Therapeutics

    World Rank (Jan-05-2024)
    4,829
    Market Cap (Jan-05-2024)
    2.607 Billion USD
    World Rank (Jul-30-2023)
    7,868
    Market Cap (Jul-30-2023)
    1.197 Billion USD
    World Rank (Dec-25-2022)
    12,906
    Market Cap (Dec-25-2022)
    0.464 Billion USD
    World Rank (Jan-07-2022)
    17,152
    Market Cap (Jan-07-2022)
    0.28 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -93 Million USD
    Annual Net Income in USD
    -106 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    CymaBay Therapeutics is a Clinical Stage Biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. The company estimated annual revenue is currently 6.8 million USD per year. The headquarters is in USA.
  6. Sterling Check Corp.

    World Rank (Jan-05-2024)
    7,483
    Market Cap (Jan-05-2024)
    1.268 Billion USD
    World Rank (Jul-30-2023)
    7,871
    Market Cap (Jul-30-2023)
    1.196 Billion USD
    World Rank (Dec-25-2022)
    6,704
    Market Cap (Dec-25-2022)
    1.446 Billion USD
    World Rank (Jan-07-2022)
    6,295
    Market Cap (Jan-07-2022)
    2.00 Billion USD
    Annual Revenue in USD
    766 Million USD
    Annual Operating Income in USD
    60 Million USD
    Annual Net Income in USD
    19 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  7. First Busey Corporation

    World Rank (Jan-05-2024)
    7,273
    Market Cap (Jan-05-2024)
    1.335 Billion USD
    World Rank (Jul-30-2023)
    7,887
    Market Cap (Jul-30-2023)
    1.189 Billion USD
    World Rank (Dec-25-2022)
    6,912
    Market Cap (Dec-25-2022)
    1.380 Billion USD
    World Rank (Jan-07-2022)
    7,102
    Market Cap (Jan-07-2022)
    1.64 Billion USD
    Annual Revenue in USD
    450 Million USD
    Annual Operating Income in USD
    161 Million USD
    Annual Net Income in USD
    128 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    First Busey Corporation is a Financial Customer Service, Community Involvement and Expanding Shareholder Value company. The headquarters is in USA.
  8. Ligand Pharmaceuticals

    World Rank (Jan-05-2024)
    7,621
    Market Cap (Jan-05-2024)
    1.227 Billion USD
    World Rank (Jul-30-2023)
    7,940
    Market Cap (Jul-30-2023)
    1.175 Billion USD
    World Rank (Dec-25-2022)
    5,769
    Market Cap (Dec-25-2022)
    1.822 Billion USD
    World Rank (Jan-07-2022)
    5,576
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Annual Revenue in USD
    196 Million USD
    Annual Operating Income in USD
    3 Million USD
    Annual Net Income in USD
    -33 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Ligand Pharmaceuticals is a Biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It is providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The headquarters is in USA.
  9. Replimune Group

    World Rank (Jan-05-2024)
    12,365
    Market Cap (Jan-05-2024)
    0.520 Billion USD
    World Rank (Jul-30-2023)
    7,950
    Market Cap (Jul-30-2023)
    1.172 Billion USD
    World Rank (Dec-25-2022)
    7,081
    Market Cap (Dec-25-2022)
    1.332 Billion USD
    World Rank (Jan-07-2022)
    8,400
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -118 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile

    Replimune Group is an emerging class of Cancer Therapeutics company that exploits the ability of viruses to selectively replicate in and kill tumors while at the same time inducing a potent, patient specific, anti tumor immune response. The headquarters is in USA.

    Facts About Company

    Replimune Group Annual Net loss for year ending Mar-2023 was -174 million USD.

    Replimune Group Annual Net loss for year ending Mar-2022 was -118 million USD.

    As on 2023, Replimune Group has 284 employees.

  10. TaskUs Inc.

    World Rank (Jan-05-2024)
    8,275
    Market Cap (Jan-05-2024)
    1.066 Billion USD
    World Rank (Jul-30-2023)
    7,965
    Market Cap (Jul-30-2023)
    1.168 Billion USD
    World Rank (Dec-25-2022)
    6,378
    Market Cap (Dec-25-2022)
    1.566 Billion USD
    World Rank (Jan-07-2022)
    3,560
    Market Cap (Jan-07-2022)
    4.49 Billion USD
    Annual Revenue in USD
    960 Million USD
    Annual Operating Income in USD
    84 Million USD
    Annual Net Income in USD
    40 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    TaskUs Inc is a digital outsourcer focused on serving high-growth technology companies to represent, protect and grow their brands. The company annual revenue is 760 million USD as on 2021. The headquarters is in USA.

Share

Ads